{"title":"Dynamic simulation of a left ventricular assist device under coupled working state with the natural heart.","authors":"Shulei Li, Xingmin Gui, Donghai Jin, Chengxuan Su, Guangmao Liu, Xihang Jiang","doi":"10.1177/03913988251335148","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The left ventricular assist device (LVAD) goes through a counterclockwise dynamic characteristic loop under heart-pump coupled working state. However, few studies have investigated the underlying physical mechanisms from the flow field perspective.</p><p><strong>Method: </strong>Computational fluid dynamic (CFD) methods are used for unsteady flow field simulations and hemolytic possibility predictions in one cardiac cycle. The pressure boundary conditions are set based on the prior in vitro experiment.</p><p><strong>Results: </strong>Flow blockage started at the inlet guide vanes (IGVs) and affected the downstream flow field at early systole, and occurred mainly at the outlet guide vanes (OGVs) during diastole. At a typical flow-rate, the residence time in IGVs accounted for 42.55% of all parts during systole whereas only 18.75% during diastole.</p><p><strong>Conclusion: </strong>The dynamic characteristic loop is closely related to the movement of vortices within the pump, as the low-speed vortices failing to respond in time to the changes in boundary conditions. An increased likelihood of adverse events is anticipated at early systole.</p><p><strong>Significance: </strong>This study reveals the physical mechanisms underlying the flow field changes within the pump during coupled working. The detailed hemolytic analysis at different cardiac events helps the subsequent real-time intelligent pump adjust strategies.</p>","PeriodicalId":13932,"journal":{"name":"International Journal of Artificial Organs","volume":" ","pages":"332-347"},"PeriodicalIF":1.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Artificial Organs","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/03913988251335148","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The left ventricular assist device (LVAD) goes through a counterclockwise dynamic characteristic loop under heart-pump coupled working state. However, few studies have investigated the underlying physical mechanisms from the flow field perspective.
Method: Computational fluid dynamic (CFD) methods are used for unsteady flow field simulations and hemolytic possibility predictions in one cardiac cycle. The pressure boundary conditions are set based on the prior in vitro experiment.
Results: Flow blockage started at the inlet guide vanes (IGVs) and affected the downstream flow field at early systole, and occurred mainly at the outlet guide vanes (OGVs) during diastole. At a typical flow-rate, the residence time in IGVs accounted for 42.55% of all parts during systole whereas only 18.75% during diastole.
Conclusion: The dynamic characteristic loop is closely related to the movement of vortices within the pump, as the low-speed vortices failing to respond in time to the changes in boundary conditions. An increased likelihood of adverse events is anticipated at early systole.
Significance: This study reveals the physical mechanisms underlying the flow field changes within the pump during coupled working. The detailed hemolytic analysis at different cardiac events helps the subsequent real-time intelligent pump adjust strategies.
期刊介绍:
The International Journal of Artificial Organs (IJAO) publishes peer-reviewed research and clinical, experimental and theoretical, contributions to the field of artificial, bioartificial and tissue-engineered organs. The mission of the IJAO is to foster the development and optimization of artificial, bioartificial and tissue-engineered organs, for implantation or use in procedures, to treat functional deficits of all human tissues and organs.